At the end of this activity, participants should be able to explain the mechanisms of action, pharmacokinetics and Food and Drug Administration-approved indications for the newest anticoagulants; discuss how clinical trial data is used to select an appropriate anticoagulant for an individual patient; and describe the safety concerns, monitoring options and reversal strategies for the newest anticoagulants. Pharmacist Michigan Pharmacists Association (MPA) is accredited by the Accreditation Council for Phar
Hide player controls
Hide resume playing